Objectives

  1. To review the history of the FDA and its implications for pharmaceutical regulation.
  2. To review the evidentiary standards used by the FDA to support new drug approval.
     

Faculty

Joseph S. Ross, MD, MHS
Associate Professor of Medicine and Public Health
Yale University 

Dr. Ross has had financial relationship(s) with commercial interest(s) with Grant/Research Support (whether received
directly or through a grant managed by an institution) FDA, CMS, NIH/NHLBI, AHRQ, Johnson & Johnson, Medtronic Inc. (all managed by Yale) Blue Cross Blue Shield Association (managed by Yale).  

Session date: 
Wednesday, May 2, 2018 - 8:00am to 9:00am
Location: 
Chestnut Conference Room 1AB
759 Chestnut St
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours
  • 1.00 BCIPE Risk Management

Please login or register to take this course.